Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

BUY
$82.37 - $107.29 $82 - $107
1 Added 0.72%
140 $12,000
Q2 2022

Aug 09, 2022

BUY
$86.5 - $128.27 $259 - $384
3 Added 2.21%
139 $13,000
Q1 2022

May 10, 2022

BUY
$101.96 - $128.34 $13,866 - $17,454
136 New
136 $16,000
Q4 2020

Feb 05, 2021

SELL
$71.69 - $91.23 $9,176 - $11,677
-128 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$67.19 - $87.44 $38,096 - $49,578
-567 Reduced 81.58%
128 $10,000
Q2 2020

Aug 10, 2020

SELL
$57.54 - $76.95 $199,548 - $266,862
-3,468 Reduced 83.31%
695 $48,000
Q1 2020

May 12, 2020

SELL
$52.41 - $81.0 $169,336 - $261,711
-3,231 Reduced 43.7%
4,163 $785,000
Q4 2019

Feb 06, 2020

BUY
$71.7 - $82.09 $488,277 - $559,032
6,810 Added 1166.1%
7,394 $1.73 Million
Q3 2019

Nov 06, 2019

BUY
$61.55 - $75.43 $18,218 - $22,327
296 Added 102.78%
584 $128,000
Q2 2019

Aug 08, 2019

SELL
$55.74 - $64.41 $696,638 - $804,996
-12,498 Reduced 97.75%
288 $53,000
Q1 2019

May 08, 2019

BUY
$47.89 - $64.05 $606,047 - $810,552
12,655 Added 9660.31%
12,786 $2.45 Million
Q4 2018

Feb 07, 2019

SELL
$46.41 - $56.94 $17,078 - $20,953
-368 Reduced 73.75%
131 $20,000
Q3 2018

Nov 08, 2018

BUY
$45.7 - $58.03 $10,373 - $13,172
227 Added 83.46%
499 $87,000
Q2 2018

Aug 07, 2018

SELL
$42.45 - $51.3 $270,109 - $326,421
-6,363 Reduced 95.9%
272 $40,000
Q1 2018

May 18, 2018

BUY
$37.19 - $47.45 $5,020 - $6,405
135 Added 2.08%
6,635 $926,000
Q3 2017

Nov 08, 2017

BUY
$36.29 - $38.83 $235,885 - $252,395
6,500
6,500 $711,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Rational Advisors LLC Portfolio

Follow Rational Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rational Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rational Advisors LLC with notifications on news.